Transfection Reagents And Equipment Market is Expected to Reach a Value of USD 1.08 billion by 2022 “The global Transfection Reagent & Equipment Market size is estimated to reach USD 1.08 billion by 2022, exhibiting a 7.4% CAGR during the forecast period. The primary factor for the growth of this segment is the rising demand for the production of the recombinant protein.�
Industry Insights The global Transfection Reagent & Equipment Market size is estimated to reach USD 1.08 billion by 2022, exhibiting a 7.4% CAGR during the forecast period. The primary factor for the growth of this segment is the rising demand for the production of the recombinant protein. Advancements in the clinical development of biopharmaceuticals, is anticipated to boost the demand for gene analysis and gene expression studies for the purpose of bio-authenticity and investigative analysis. The aforementioned factor is attributive to drive the segment revenue potentially in the coming years. Patent cliff generated in recent years is pronouncing the need for production of several moieties which depends on the laboratory analysis thus inducing industrial growth in this market. Anticipated rise in the analytical methods is expected to increase the adoption of such technologies in the coming years. Additionally, with established healthcare infrastructure and reimbursement policy, many pharma companies are expanding their business in western geographic segments which would induce innovation and growth in the biotechnology industry over the forecasted period. Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/transfection-reagentsequipment-market/request-sample Method Insights Electroporation method for conducting transfection process holds the largest share of the revenue. The larger share is attributive to its diverse versatility in application, user-friendliness, and consequent higher implementation of this technique. However, the misuse of this method has caused cell damage which is expected to slow down its adoption. Liposomal method is second only to the electroporation method of transfection. The other segments for the implementation of method includes adenoviral vectors and particle bombardment which are expected to provide positive growth in the forecasted period.